Clinical trial · Interventional
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
NCT06589414CI-TRIAL-00114923DAMeGecompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective, multicentric, regional study designed to assess the feasibility of setting up a summary consultation with a general practitioner (GP) to complement the consultation for the announcement of a cancer diagnosis. 171 patients will be included in the study. Each patient will be followed for 6 months.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumours | Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- DAMeGe protocol
- interventionNames
- Other: Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)
Primary outcomes (1)
- measure
- The ratio between the number of patients who attended the summary consultation with the general practitioner within 15 days of being diagnosed with cancer in the referral care centre and the total number of patients included in the study.
- timeFrame
- 15 days after the end of the recruitment
Secondary outcomes (10)
- measure
- The reasons why the summary consultation with the GP did not take place within 15 days of the consultation to announce the cancer diagnosis.
- timeFrame
- 21 months after the start of the study
- description
- It will be assessed for each patient included in the study in conjunction with the patients or GPs: patient refusal, GP refusal, cancelled or postponed by the patient, cancelled or postponed by the GP, out of time (\>15 days), other reason.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 18 years. 2. Patient with a solid tumour whatever the organ. 3. Patient treated in one of the participating centres as part of a system for announcing the diagnosis of a solid cancer. 4. Patient undergoing cancer treatment in one of the participating centres. 5. Patient with a registered general practitioner in the Occitanie region. 6. Patient affiliated to a French Social Security scheme. 7. Patient having signed informed consent prior to inclusion in the study and prior to any specific procedure for the study. Exclusion Criteria: 1. Patient already included in another clinical trial concerning a care pathway. 2. Patient deprived of liberty or under legal protection (curatorship and guardianship, safeguard of justice). 3. Pregnant or breast-feeding woman.
References
Publications (0)
Data not yet available
No reference posted for this study.